Clinical Trial Update: Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD) [NA]

View source ↗

Summary

This document notes an active-not-recruiting clinical trial evaluating NUV001 supplementation in patients with Sickle Cell Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• NUV001

Snippet

Sponsor: LGD | Conditions: Sickle Cell Disease | NA | Status: ACTIVE_NOT_RECRUITING